Reported side effects are typically mild and transient: BPC-157: Nausea (rare), mild fatigue in the first week, minor injection site redness TB-500: Mild lethargy during the loading phase, transient head rush immediately after injection, injection site discomfort Combined stack: No documented synergistic toxicity in preclinical or clinical observational data The more significant risks relate to sourcing and administration rather than the peptides themselves
What is Epithalon being researched for
The translational significance of the neurovascular unit
Cell Mol Biol Lett 27(1):60 Zalpoor H, Rezaei M, Yahyazadeh S, Ganjalikhani-Hakemi M (2022h) Flt3-ITD mutated acute myeloid leukemia patients and COVID-19: potential roles of autophagy and HIF-1 in leukemia progression and mortality
Biochemistry, 39(42), 13005-13011
Follow the product label and any lot-specific documentation